2-(dimethylsulfamoylamino)-3-[2-oxo-5-(2-phenylethyl)-4-propan-2-ylpyrimidin-1-yl]propanoic acid
C20H28N4O5S — CID 163936515
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(dimethylsulfamoylamino)-3-[2-oxo-5-(2-phenylethyl)-4-propan-2-ylpyrimidin-1-yl]propanoic acid
2-(dimethylsulfamoylamino)-3-[2-oxo-5-(2-phenylethyl)-4-propan-2-ylpyrimidin-1-yl]propanoic acid (PubChem CID 163936515) has the molecular formula C20H28N4O5S and a molecular weight of 436.53 g/mol. Its IUPAC name is 2-(dimethylsulfamoylamino)-3-[2-oxo-5-(2-phenylethyl)-4-propan-2-ylpyrimidin-1-yl]propanoic acid.
Molecular Properties
| Compound Name | 2-(dimethylsulfamoylamino)-3-[2-oxo-5-(2-phenylethyl)-4-propan-2-ylpyrimidin-1-yl]propanoic acid |
|---|---|
| PubChem CID | 163936515 |
| Molecular Formula | C20H28N4O5S |
| Molecular Weight | 436.53 g/mol |
| Exact Mass | 436.18 |
| IUPAC Name | 2-(dimethylsulfamoylamino)-3-[2-oxo-5-(2-phenylethyl)-4-propan-2-ylpyrimidin-1-yl]propanoic acid |
| SMILES | CC(C)c1nc(=O)n(CC(NS(=O)(=O)N(C)C)C(=O)O)cc1CCc1ccccc1 |
| InChI | InChI=1S/C20H28N4O5S/c1-14(2)18-16(11-10-15-8-6-5-7-9-15)12-24(20(27)21-18)13-17(19(25)26)22-30(28,29)23(3)4/h5-9,12,14,17,22H,10-11,13H2,1-4H3,(H,25,26) |
| InChIKey | RNHGTHCPPRNYJX-UHFFFAOYSA-N |
| XLogP | 1.00 |
| TPSA | 121.60 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.53 |
| LogP ≤ 5 | 1.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163936515 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.